These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18936525)

  • 1. Relationship between dyskerin expression and telomerase activity in human breast cancer.
    Montanaro L; Calienni M; Ceccarelli C; Santini D; Taffurelli M; Pileri S; Treré D; Derenzini M
    Cell Oncol; 2008; 30(6):483-90. PubMed ID: 18936525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer.
    Montanaro L; Brigotti M; Clohessy J; Barbieri S; Ceccarelli C; Santini D; Taffurelli M; Calienni M; Teruya-Feldstein J; Trerè D; Pandolfi PP; Derenzini M
    J Pathol; 2006 Sep; 210(1):10-8. PubMed ID: 16841302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyskerin and TERC expression may condition survival in lung cancer patients.
    Penzo M; Ludovini V; Treré D; Siggillino A; Vannucci J; Bellezza G; Crinò L; Montanaro L
    Oncotarget; 2015 Aug; 6(25):21755-60. PubMed ID: 26301749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing.
    Mochizuki Y; He J; Kulkarni S; Bessler M; Mason PJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10756-61. PubMed ID: 15240872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.
    Alawi F; Lin P
    Mol Carcinog; 2011 May; 50(5):334-45. PubMed ID: 21480387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells.
    Iarriccio L; Manguán-García C; Pintado-Berninches L; Mancheño JM; Molina A; Perona R; Sastre L
    PLoS One; 2015; 10(11):e0142980. PubMed ID: 26571381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of dyskerin expression with active proliferation independent of telomerase.
    Alawi F; Lin P; Ziober B; Patel R
    Head Neck; 2011 Jul; 33(7):1041-51. PubMed ID: 21674675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation.
    Montanaro L; Calienni M; Bertoni S; Rocchi L; Sansone P; Storci G; Santini D; Ceccarelli C; Taffurelli M; Carnicelli D; Brigotti M; Bonafè M; Treré D; Derenzini M
    Cancer Res; 2010 Jun; 70(11):4767-77. PubMed ID: 20501855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and Tumour Tissue mRNA Expressions of Telomerase Complex Genes in Several Types of Cancer.
    Çalışkan Can E; Atalay MC; Miser Salihoğlu E; Yalçıntaş Arslan Ü; Şimşek HB; Yardım Akaydın S
    Balkan Med J; 2017 May; 34(3):269-274. PubMed ID: 28443573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.
    MacNeil DE; Lambert-Lanteigne P; Autexier C
    Nucleic Acids Res; 2019 Jun; 47(10):5368-5380. PubMed ID: 30931479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance.
    Garus A; Autexier C
    RNA; 2021 Dec; 27(12):1441-1458. PubMed ID: 34556550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
    Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
    Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
    Vulliamy TJ; Dokal I
    Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiscale in situ analysis of the role of dyskerin in lung cancer cells.
    Fernandez-Garcia I; Marcos T; Muñoz-Barrutia A; Serrano D; Pio R; Montuenga LM; Ortiz-de-Solorzano C
    Integr Biol (Camb); 2013 Feb; 5(2):402-13. PubMed ID: 23233094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of telomerase activity by six telomerase subunits.
    Chang JT; Chen YL; Yang HT; Chen CY; Cheng AJ
    Eur J Biochem; 2002 Jul; 269(14):3442-50. PubMed ID: 12135483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin.
    O'Brien R; Tran SL; Maritz MF; Liu B; Kong CF; Purgato S; Yang C; Murray J; Russell AJ; Flemming CL; von Jonquieres G; Pickett HA; London WB; Haber M; Gunaratne PH; Norris MD; Perini G; Fletcher JI; MacKenzie KL
    Cancer Res; 2016 Jun; 76(12):3604-17. PubMed ID: 27197171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer.
    Montanaro L
    J Pathol; 2010 Dec; 222(4):345-9. PubMed ID: 20925138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.